COURSE DETAILS This course is specifically designed for gastroenterologists, hepatologists, surgeons, Gl transplant hepatology nurses, and other health care providers who treat patients with digestive diseases; and who are interested in keeping abreast of the latest advances in research and state of the art clinical practices in the field of gastroenterology and hepatology. A distinguished and experienced UW faculty panel will share this knowledge through discussion of selected and relevant research findings with topics including the diagnosis and treatment of Gl and liver diseases, evidence-based research affecting clinical practice, and new developments in technology and procedural innovations. In addition to our own experienced UW Faculty, we have two national thought leaders visiting who will provide their perspective on the treatment of NASH and Inflammatory Bowel Disease. COURSE OBJECTIVES Upon completion of this activity, participants will be able to: Define recent developments in the diagnosis and treatment of GI and liver diseases; Discuss the state-of-the-art of colorectal cancer screening; Discuss evidence-based research that affects the practice of clinical gastroenterology and hepatology; and Apply evidence-based approach to construct new treatment strategies.


Sponsored by the University of Washington School of Medicine Office of Continuing Medical Education and the Division of Gastroenterology.

The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designated this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.


UWGI Allied Health (RN/NP/PA/ND): $0.00

UWGI Faculty, Fellow or Provider (MD/DO): $0.00

Allied Health without CME Credit (RN/NP/PA/ND): $75.00

Allied Health with CME Credit (RN/NP/PA/ND): $115.00

Provider without CME Credit (MD/DO): $75.00

Provider with CME Credit (MD/DO): $115.00


The University of Washington Division of Gastroenterology would like to thank the following sponsors and exhibitors for their generous support:

Abbvie, Dova, Novartis, Takeda.
Boston Scientific, Cook Medical, Exact Sciences, Gilead, Intercept, Medtronic, MeritMedical, Olympus, Salix.


Please Contact Program Coordinator:
Kelsey Griffin: kgriffin@medicine.washington.edu

  • NASH Pathologies and Targets of Therapy - Brent A. Tetri, MD

    Brent A. Tetri, MD (Guest Speaker)
    Professor & Director, Division of Gastroenterology & Hepatology
    St. Louis University School of Medicine

    Dr. Tetri has played an important leadership role in a small and select group of researchers funded by the NIH to study fatty liver disease – the NASH Clinical Research Network. Over the course of the last decade, they have come up with now-standard definitions of the disease, and they continue to follow a large number of patients recruited from Saint Louis University and other centers around the country to determine the outcomes of having fatty liver disease. In the midst of doing this, these researchers have begun to find new ways of treating fatty liver disease and Dr. Tetri has made Saint Louis University into a national center of excellence trying to discover treatments for this potentially fatal disease.

    Disclosure Information: Allergan, Arrowhead, Blade, Boehringer Ingleheim, BMS, Coherus, Consynance, Enanta, Gelesis, Gilead, Intercept, Lipocine, Madrigal, Medimmune, Merck, Metacrine, NGM, pH-Pharma, Prometheus.

  • Risk Stratification for HCC Screening - George N. Ioannou, MD, MS

    George N. Ioannou, MD, MS
    Professor & Director of Hepatology
    VA Puget Sound Health Care System

    Dr. Ioannou is a professor based at the VA Puget Sound Health Care System. He specializes in hepatitis C, non-alcoholic fatty liver disease, iron deficiency and iron overload. Dr. Ioannou is also Chair of the AASLD Practice Guidelines.
    Disclosure Information: This speaker does not have any relationships to disclose.

  • Updates in Autoimmune Hepatitis, PBC and PSC - Anne M. Larson, MD

    Anne M. Larson, MD
    Clinical Professor & Chief, Liver Clinic
    UW Medicine - Northwest Hospital

    Dr. Larson is the Clinic Chief of the UW Medicine/Northwest Hospital Liver Clinic and a UW Clinical Professor of Medicine. She is a nationally recognized clinician, researcher and lecturer, the author of numerous peer-reviewed publications, and is recognized as a leader in the field of hepatology.
    Disclosure Information: Consultant/Board Member, American Board of Internal Medicine

  • Improving Access to Liver Transplantation: HCV NAT Positive Liver Grafts - Renuka Bhattacharya, MD

    Renuka Bhattacharya, MD
    Clinical Associate Professor & Clinical Chief of Hepatology
    UW Medicine - Liver Care Line

    Dr. Bhattacharya is a hepatologist, caring for patients with liver disease and those requiring liver transplant care. She is the medical director of the University of Washington liver transplant program and a UW assistant professor of medicine. Her interests include the treatment of hepatocellular carcinoma (liver cancer), liver transplant, hepatitis B and C, autoimmune hepatitis, PSC, PBC, in addition to other acute and chronic liver diseases.
    Disclosure Information: This speaker does not have any relationships to disclose.

  • Interventional Radiology Interventions for Portal Hypertension - Christopher R. Ingraham, MD

    Christopher R. Ingraham, MD
    Assistant Professor, Interventional Radiology
    UW Medicine - UW Medical Center

    Dr. Ingraham is currently an assistant professor in the section of Interventional Radiology in the Department of Radiology at the University of Washington. He also serves as the founding Program Director for the newly formed IR Residency, and the director of the IR fellowship. Dr. Ingraham’s clinical interests include trauma interventions, dialysis access and interventions, hepatobiliary disease, vascular anomalies, uterine fibroid embolization, difficult IVC Filter removal, and solid organ transplant interventions.
    Disclosure Information: This speaker does not have any relationships to disclose.

  • Pregnancy and Women's Issues in Inflammatory Bowel Disease - Bincy P. Abraham, MD, MS

    Bincy P. Abraham, MD, MS (Guest Speaker)
    Fondren Distinguished Professor in Inflammatory Bowel Disease
    Houston Methodist, Weill Cornell Medical College

    Dr. Abraham is an associate professor of clinical medicine in the Academic Division of Gastroenterology and Hepatology at Houston Methodist – Weill Cornell in Houston, Texas. She earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease. During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California.
    Disclosure Information: Research, Janssen, Celgene, Abbvie, UCB, Takeda, Lilly. Consultant: Takeda, Janssen, UCB, Pfizer, Samsung Bioepis.
    Speaker: Janssen, UCB, Takeda, Pfizer. No CME.

  • Colorectal Cancer Screening - Jason A. Dominitz, MD, MHS

    Jason A. Dominitz, MD, MHS
    Professor & GI Section Chief, VA Puget Sound Health Care System
    National Program Director for Gastroenterology, Department of Veterans Affairs

    Dr. Dominitz is a gastroenterologist with a strong clinical interest in colorectal cancer screening and improving the quality of colonoscopy. Dr. Dominitz has gained a national reputation for his work in colorectal cancer screening. He is a prolific researcher with over 80 peer-reviewed publications. He has also published dozens of guidelines on the clinical practice of gastroenterology. Many of these guidelines come from his eight years serving on the American Society for Gastrointestinal Endoscopy’s Standards of Practice Committee (3 years as committee chair). He is currently a member of the U.S. Multi-Society Task Force on Colorectal Cancer.
    Disclosure Information: This speaker does not have any relationships to disclose.

  • Barrett's Esophagus - Anand Singla, MD, MS

    Anand Singla, MD, MS
    Clinical Assistant Professor, Digestive Health Center
    UW Medicine - UW Medical Center

    Dr. Singla is a Clinical Assistant Professor at the UW Medicine Digestive Health Center. He graduated cum laude from the University of Pennsylvania with a degree in Biology. He then began his medical education at the University of Massachusetts School of Medicine. Dr. Singla extended his medical education by a year to pursue clinical outcomes and epidemiology research training at the University of Massachusetts Surgical Outcomes and Epidemiology Analysis Research Center. He completed his Gastroenterology Fellowship at the University of Washington, where he also pursued a Masters in Public Health. Dr. Singla has recently completed his Therapeutic Fellowship as a Clinical Instructor at Northwestern University in Chicago.
    Disclosure Information: This speaker does not have any relationships to disclose.

  • Complicated Polypectomies - Bryan L. Balmadrid, MD

    Bryan L. Balmadrid, MD
    Clinical Assistant Professor & HMC GI Clinical Chief
    UW Medicine - Harborview Medical Center

    Dr. Balmadrid is a UW clinical assistant professor of gastroenterology and director of endoscopy at Harborview Medical Center specializing in advanced endoscopic procedures. In addition to board certification in internal medicine and gastroenterology, he received additional specialized training in advanced endoscopic procedures which include endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), and balloon enteroscopy. He specializes in direct endoscopic necrosectomy of pancreas necrosis and pancreaticobiliary trauma.
    Disclosure Information: This speaker does not have any relationships to disclose.

  • New Biologic Agents in Inflammatory Bowel Disease - Jason W. Harper, MD

    Jason W. Harper, MD
    Clinical Assistant Professor & Director, Harbroview IBD Program
    UW Medicine - Harborview Medical Center

    Dr. Harper is the director of the Harborview Medical Center Inflammatory Bowel Disease program, and is a UW clinical assistant professor. He earned his M.D. from Columbia University, and did his internal medicine and gastroenterology training at the University of Washington. He is a member of the Crohn's and Colitis Foundation, and is presently on the regional Medical Advisory Committee. Dr. Harper's clinical interests include inflammatory bowel diseases (ulcerative colitis and Crohn's disease) His research interests include clinical outcomes in IBD.
    Disclosure Information: This speaker does not have any relationships to disclose. No CME.





Questions? Contact Program Coordinator:
Kelsey Griffin |